MIAMI , Dec. 22 -- The latest free Apple iPhone app to hit the iTunes store is CA123 , an aggregator of the latest news and information about cancer and cancer treatments for patients, the public and professionals. CA123 links to its home ...
MARSEILLE, France, Dec. 21 Ipsogen SA (Alternext: ALIPS) today announced that a new study confirming the pivotal role of tumor grade in chemotherapy prescription has been presented at the 32nd Annual San Antonio Breast Cancer Symposium ...
-- Phase III trials of OGX-011 in first- and second-line advanced prostate cancer and non-small cell lung cancer, expected to begin in 2010 and early 2011 -- -- Significantly strengthens Teva's oncology offerings with novel therapeutic ...
SEATTLE, Dec. 18 Despite a 100-fold increase in H1N1 influenza cases in the Seattle area during spring 2009, an aggressive infection control program to protect immunocompromised cancer patients and thorough screening measures resulted in no ...
QUEBEC CITY , Dec. 18 /PRNewswire-FirstCall/ - Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with ...
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)-652-2626 Intl: +1 805-652-2626 ...
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group Dodi Handy, President and CEO ( Twitter: @dodihandy ) For Media Inquiries: Kathy Addison, Director, Elite Media Group ...
FLUSHING, N.Y. , Dec. 17 /PRNewswire-USNewswire/ -- A 58-year-old man who lives in Corona , Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not ...
JACKSON, N.J. , Dec. 17 -- The Center for Modeling Optimal Outcomes, LLC, a New Jersey based think tank focused on the application of neuroscience in business, inadvertently discovered a scientifically verifiable model for assessing ...
SEATTLE, Dec. 17 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) will review the New Drug Application (NDA) for ...
Discover how the U.S. plans to invest $7.2 billion in cancer research for 2025 and learn about top states, charities, and key factors influencing cancer research.
Discover how a groundbreaking blood test using advanced DNA sequencing techniques is set to revolutionize early cancer detection.
Breakthrough in cancer detection: Biolaser can detect pancreatic and lung cancer cells early without destroying them.
Artificial Intelligence enhances the accuracy of ovarian cancer detection, offering more reliable and timely diagnoses for better patient outcomes.
New research shows that cellular architecture can predict how kidney cancer patients will respond to treatment, offering potential for more personalized therapies.
Subscribe to our Free Newsletters!